Nio has been expanding its brand portfolio to help it address larger segments of the market and cater to more niche needs.

NIO's Q4 deliveries fell short of expectations, highlighting sluggish growth in the competitive Chinese market. See why I'm ...

Organovo Holdings, Inc. (ONVO), a clinical-stage biotech firm focused on advancing innovative treatments for inflammatory bowel ...

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to ...

Although Li Auto doesn’t break down the key drivers of its growth, it’s quite likely that the Li L6, the most affordable ...

NIO's vehicle lineup and expansion efforts bode well for the long term, but persistent losses, financial strain, and rising ...

Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...

NIO-SW (09866.HK) (NIO.US) and its second brand, Onvo, jointly announced the launch of a limited-time last resort policy to ...

TMTPOST -- Chinese electric vehicle (EV) makers led by BYD Co. Ltd. finished the year 2024 with new monthly records, ...

NIO Inc.'s December delivery results have come as a surprise for many. The rigorous ramp of ONVO deliveries in the final weeks of 2024, alongside restored core brand sales at the 20,000+ monthly ...

Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ...

Trust a Chinese automaker to consistently push the boundaries of innovation. This time, it's the Shanghai-based electric car ...